1453 related articles for article (PubMed ID: 8384312)
1. Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2.
Cerretti DP; Kozlosky CJ; Vanden Bos T; Nelson N; Gearing DP; Beckmann MP
Mol Immunol; 1993 Mar; 30(4):359-67. PubMed ID: 8384312
[TBL] [Abstract][Full Text] [Related]
2. Malignant melanoma: reduced risk associated with early childbearing and multiparity.
Lambe M; Thörn M; Sparén P; Bergström R; Adami HO
Melanoma Res; 1996 Apr; 6(2):147-53. PubMed ID: 8791273
[TBL] [Abstract][Full Text] [Related]
3. Salpêtrière Hospital experience with biochemotherapy in metastatic melanoma.
Antoine EC; Benhammouda A; Bernard A; Youssef A; Mortier N; Gozy M; Nizri D; Auclerc G; Rocher MA; Soubrane CL; Weil M; Khayat D
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S16-21. PubMed ID: 9457388
[TBL] [Abstract][Full Text] [Related]
4. The antimetabolite Tiazofurin (TR) inhibits glycoconjugate biosynthesis and invasiveness of tumour cells.
Tímár J; Tóvári J; Pogány G; Ladányi A; Paku S; Rśó E; Bocsi J; Jeney A; Lapis K
Eur J Cancer; 1996 Jan; 32A(1):152-9. PubMed ID: 8695225
[TBL] [Abstract][Full Text] [Related]
5. Endothelial CD44H mediates adhesion of a melanoma cell line to quiescent human endothelial cells in vitro.
Price EA; Coombe DR; Murray JC
Int J Cancer; 1996 Feb; 65(4):513-8. PubMed ID: 8621236
[TBL] [Abstract][Full Text] [Related]
6. Culture of tumour-infiltrating lymphocytes from melanoma and colon carcinoma: removal of tumour cells does not affect tumour-specificity.
Mulder WM; Stukart MJ; Roos M; van Lier RA; Wagstaff J; Scheper RJ; Bloemena E
Cancer Immunol Immunother; 1995 Nov; 41(5):293-301. PubMed ID: 8536275
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous side effects associated with interleukin 2 administration for metastatic melanoma.
Wolkenstein P; Chosidow O; Wechsler J; Guillaume JC; Lescs MC; Brandely M; Avril MF; Revuz J
J Am Acad Dermatol; 1993 Jan; 28(1):66-70. PubMed ID: 8425972
[TBL] [Abstract][Full Text] [Related]
8. Preparation of two dosage forms containing antitumor prostaglandin and their antitumor effect in vitro and in vivo: Lipiodol solution for i.a. administration and lipid microspheres for i.p. or i.v. administration.
Shoji F; Masahiro N; Yoshikazu T; Masanori F
Adv Exp Med Biol; 1997; 400B():955-61. PubMed ID: 9547652
[No Abstract] [Full Text] [Related]
9. Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells.
Matsuura N; Puzon-McLaughlin W; Irie A; Morikawa Y; Kakudo K; Takada Y
Am J Pathol; 1996 Jan; 148(1):55-61. PubMed ID: 8546226
[TBL] [Abstract][Full Text] [Related]
10. Influence of hepatocyte growth factor/scatter factor on the metastatic phenotype of B16 melanoma cells.
Rusciano D; Lin S; Lorenzoni P; Casella N; Burger MM
Tumour Biol; 1998; 19(5):335-45. PubMed ID: 9701724
[TBL] [Abstract][Full Text] [Related]
11. Diffuse melanosis and trichochromuria in malignant melanoma.
Agrup G; Agrup P; Hansson C; Rorsman H; Rosengren E
Acta Derm Venereol; 1979; 59(5):456-7. PubMed ID: 93371
[TBL] [Abstract][Full Text] [Related]
12. Critical determinants of melanoma metastasis.
Fidler IJ
J Investig Dermatol Symp Proc; 1996 Apr; 1(2):203-8. PubMed ID: 9627717
[TBL] [Abstract][Full Text] [Related]
13. [TNM classification of malignant melanoma and non-melanoma skin cancer].
Suzuki T; Inoue Y; Kiyohara Y; Ikeda S
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2163-9. PubMed ID: 9388531
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous malignant melanoma in young adults under age 30.
Tamir G; Milo Y; Rothem A; Sulkes J; Hauben DJ
Isr J Med Sci; 1996 Dec; 32(12):1290-6. PubMed ID: 9007174
[TBL] [Abstract][Full Text] [Related]
15. Immunopathological analysis of mucosal melanocyte distribution in the human lower lip of the elderly.
Yanagi K; Haneji N; Ishimaru N; Hamano H; Hayashi Y
Pathobiology; 1996; 64(3):156-60. PubMed ID: 8910925
[TBL] [Abstract][Full Text] [Related]
16. Congenital melanoma: a case suggesting rhabdomyogenic differentiation.
Koyama T; Murakami M; Nishihara O; Masuda T
Pediatr Dermatol; 1996; 13(5):389-93. PubMed ID: 8893239
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of HLA-DR expression and antigen presentation in Toxoplasma gondii-infected melanoma cells by interleukin 6 and interferon gamma.
Yang TH; Aosai F; Norose K; Ueda M; Yano A
Microbiol Immunol; 1996; 40(6):443-9. PubMed ID: 8839430
[TBL] [Abstract][Full Text] [Related]
18. Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population.
Ródenas JM; Delgado-Rodríguez M; Herranz MT; Tercedor J; Serrano S
Cancer Causes Control; 1996 Mar; 7(2):275-83. PubMed ID: 8740740
[TBL] [Abstract][Full Text] [Related]
19. Isolated left ventricular filling abnormalities may predict interleukin-2-induced cardiovascular toxicity.
Citterio G; Fragasso G; Rossetti E; Di Lucca G; Bucci E; Foppoli M; Guerrieri R; Matteucci P; Polastri D; Scaglietti U; Tresoldi M; Chierchia SL; Rugarli C
J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):134-41. PubMed ID: 8732696
[TBL] [Abstract][Full Text] [Related]
20. Nonspecific cell-mediated cytotoxicity in the seawater teleosts (Sparus aurata and Dicentrarchus labrax): ultrastructural study of target cell death mechanisms.
Meseguer J; Esteban MA; Mulero V
Anat Rec; 1996 Apr; 244(4):499-505. PubMed ID: 8694285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
